|
CHD9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.761100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.152300E-04 |
| Normal-vs-Stage2 |
2.335800E-01 |
| Normal-vs-Stage3 |
1.166760E-01 |
| Normal-vs-Stage4 |
3.231100E-04 |
| Stage1-vs-Stage2 |
5.196400E-01 |
| Stage1-vs-Stage3 |
7.678600E-01 |
| Stage1-vs-Stage4 |
3.136400E-01 |
| Stage2-vs-Stage3 |
7.912600E-01 |
| Stage2-vs-Stage4 |
2.027200E-01 |
| Stage3-vs-Stage4 |
2.190000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.603680E-03 |
| Normal-vs-AfricanAmerican |
1.797970E-03 |
| Normal-vs-Asian |
2.522100E-03 |
| Caucasian-vs-AfricanAmerican |
6.179400E-01 |
| Caucasian-vs-Asian |
9.643600E-02 |
| AfricanAmerican-vs-Asian |
4.533600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.29579999999818E-05 |
| Normal-vs-Female |
4.567200E-01 |
| Male-vs-Female |
1.067810E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.599500E-04 |
| Normal-vs-Extreme_Weight |
2.19469999999111E-05 |
| Normal-vs-Obese |
1.197190E-01 |
| Normal-vs-Extreme_Obese |
1.189560E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.419600E-01 |
| Normal_Weight-vs-Obese |
1.170360E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.777400E-01 |
| Extreme_Weight-vs-Obese |
3.780300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.867800E-01 |
| Obese-vs-Extreme_Obese |
5.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.357800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.057900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.53939999999864E-05 |
| Normal-vs-Age(81-100Yrs) |
3.211800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.585800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.247000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.902360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.038400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.035900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.603910E-03 |
| Normal-VS-Type2 PRCC |
8.31070000000267E-05 |
| Normal-VS-KIRP CIMP |
3.369400E-01 |
| Normal-VS-Unclassified PRCC |
8.255600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.062800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.994800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.482250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.857000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.897900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.518600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60431999999266E-05 |
| Normal-vs-N1 |
4.278100E-02 |
| Normal-vs-N2 |
1.337680E-02 |
| N0-vs-N1 |
2.024000E-01 |
| N0-vs-N2 |
8.750800E-01 |
| N1-vs-N2 |
4.819600E-01 |
|
|
